| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Min-Jun Liao, Jun Li, Wei Dang, Dong-Bo Chen, Wan-Ying Qin, Pu Chen, Bi-Geng Zhao, Li-Ying Ren, Ting-Feng Xu, Hong-Song Chen and Wei-Jia Liao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the National Natural Science Foundation of China |
81372163 |
| the Natural Science Foundation of Guangxi |
2018GXNSFDA138001 |
| the Science and Technology Planning Project of Guilin |
20190218-1 |
| the Openin Project of Key laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Ministry of Education |
GKE-KF202101 |
| the Program of Guangxi Zhuang Autonomous Region Health and Family Planning Commission |
Z20210706 |
| the Program of Guangxi Zhuang Autonomous Region Health and Family Planning Commission |
Z20190665 |
|
| Corresponding Author |
Wei-Jia Liao, MD, Chief Doctor, Professor, Laboratory of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Guilin Medical University, No. 15 Lequn Road, Xiufeng District, Guilin 541001, Guangxi Zhuang Autonomous Region, China. liaoweijia288@163.com |
| Key Words |
Liver; Fibrosis; Cirrhosis; Prediction; Novel noninvasive marker; Chronic hepatitis B |
| Core Tip |
Chronic hepatitis B virus (HBV) infection is highly endemic in China, and routine assessment of chronic hepatitis B patients is greatly needed to guide management and indicate the need for treatment. In this study, we established a new index to stage liver fibrosis and cirrhosis in patients with chronic HBV infection in China. In addition, the study compared the predictive performance between the new index and other noninvasive indices. The new index is suitable for regular monitoring and is crucial for the management of patients with liver fibrosis/cirrhosis. |
| Publish Date |
2022-07-18 09:47 |
| Citation |
Liao MJ, Li J, Dang W, Chen DB, Qin WY, Chen P, Zhao BG, Ren LY, Xu TF, Chen HS, Liao WJ. Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China. World J Gastroenterol 2022; 28(27): 3503-3513 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i27/3503.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i27.3503 |
